In one paragraphArticle in Pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Keita MasudaDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.ORCID 0000-0002-9646-9262 Yasuhiro NakagawaDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Quentin BoussauCentre de Biologie Structurale, CNRS UMR 5048, INSERM U1054, Université de Montpellier, 29 Rue de Navacelles, 34090 Montpellier, France.ORCID 0009-0005-5221-1154 Emilie ChabertCentre de Biologie Structurale, CNRS UMR 5048, INSERM U1054, Université de Montpellier, 29 Rue de Navacelles, 34090 Montpellier, France.
Tsukuru MasudaDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Jerome BonnetCentre de Biologie Structurale, CNRS UMR 5048, INSERM U1054, Université de Montpellier, 29 Rue de Navacelles, 34090 Montpellier, France.
Tatsuya InukaiDepartment of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.
Shigeki NakamuraDepartment of Microbiology, Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan.ORCID 0000-0001-5272-8886 Madoka TakaiDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.ORCID 0000-0002-6238-6717 Diego CattoniCentre de Biologie Structurale, CNRS UMR 5048, INSERM U1054, Université de Montpellier, 29 Rue de Navacelles, 34090 Montpellier, France.ORCID 0000-0002-0048-8531 Horacio CabralDepartment of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
Funding
Gap Fund Program of The University of Tokyo NAJapan Society for the Promotion of Science 22K19541Japan Society for the Promotion of Science 23H00546Japan Society for the Promotion of Science JP12345678
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Escherichia coliGemifloxacinGram-negative bacteriaphosphatidylethanolamineSchiff basetargeted therapy
Identifiers
PMID41599179
PMCPMC12845377
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390